1. Bacheler, L., van Marck, H., Maguire, T., Van Den Bulcke, T., de Béthune, M.-P., Lecocq, P., 2002. The VirtualPhenotype™: quantitative prediction of HIV drug susceptibility from viral genotype. In: Sixth International Congress on Drug Therapy in HIV Infection (Abstract PL5.5).
2. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS;Baxter;AIDS,2000
3. Birkner, M.D., van der Laan, M.J., 2005. Application of a variable importance measure method to HIV-1 sequence data. U.C. Berkeley Division of Biostatistics Working Paper Series. Working Paper 196.
4. Castor, D., Vlahov, D., Berkman, A., Wu, Y., Hammer, S.M., 2004. Genotypic sensitivity score predicts HIV viral suppression among treatment experienced patients with advanced HIV disease receiving modified DOT MedGenMed. 6. In: The XV International AIDS Conference (Abstract WePeB5751).
5. Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors;Clark;AIDS,2006